TDOC Teladoc Health Inc.

Teladoc Health to Announce Third Quarter 2024 Financial Results

Teladoc Health to Announce Third Quarter 2024 Financial Results

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For international participants, please visit the following link for global dial-in numbers: . A live audio webcast will also be available online at .

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit .

Investors:

Michael Minchak



617-444-9612



EN
16/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health to Announce Third Quarter 2024 Financial Results

Teladoc Health to Announce Third Quarter 2024 Financial Results PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For international participants, p...

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 30...

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 PURCHASE, NY, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to three new employees. Effective October 1, 2024, in connection with commencing employment, three new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 105,000 shares of Teladoc Health’s common stock, par value $0.001 per share. The restricted stock units vest, based on cont...

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee. Effective September 1, 2024, in connection with commencing employment as Senior Vice President of Product, BetterHelp, Terre Layton was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share. The restricted stock units vest, based on continued se...

Teladoc Health Inc: 2 directors

Two Directors at Teladoc Health Inc sold/sold after exercising options 21,241 shares at 7.260USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch